86 research outputs found

    Environmentally assisted cracking of a single crystal nickel-based superalloy

    Get PDF
    Single crystal material, of CMSX-4® alloy composition, was cast and secondary orientation was controlled at the machining stage, to produce c-ring cross-section tubes with known crystallographic orientations. The c-ring tubes were coated with NaCl before being subject to loading up to 700MPa and heated for durations of up to 2 hrs at 550°C in flowing environments containing air and SO2. No cracking was observed in short term tests that were run in the absence of either NaCl, or SO2, indicating a symbiotic interaction is required to initiate cracking. Experiments confirm the presence of oxygen, chlorine and sulphur at the crack tips, formed along {001} crystallographic planes, however, they were distributed discretely, with several oxide and sulphide phases observed. In this work, we image, analyse and identify the phases formed during the cracking and corrosion of CMSX-4® superalloy and hypothesise on the complex chemical interactions that take place during crack initiation

    Microstructure and oxide particle stability in a novel ODS γ-TiAl alloy processed by spark plasma sintering and laser additive manufacturing

    Get PDF
    In this work, a novel oxide dispersion strengthened titanium aluminide alloy (Ti-45Al-3Nb-<0.2Y2O3 at.%) was developed for powder-based processing technologies with a focus on spark plasma sintering and additive manufacturing. Titanium aluminides are promising structural intermetallics for weight reduction and an increased performance of high temperature components. The alloy design and selection process was supported by computational thermodynamics based on the CALPHAD approach, taking into account requirements for processing as well as long term alloy behavior under service conditions. Processing trials using spark plasma sintering, direct metal deposition and selective laser melting were conducted to study the alloy behavior, microstructure formation and introduction as well as stability of the ODS particles. Additionally, thermal annealing on the sintered and laser consolidated material was performed. Conventional dual phase α2-Ti3Al and γ-TiAl duplex and near-lamellar microstructures were obtained from the processed material. The ODS particles were homogeneously distributed in the alloy matrix after processing in the liquid state. For the direct metal deposition process, the novel alloy was compared to the established GE48-2-2 alloy (Ti-48Al-2Cr-2Nb) in terms of phases, microstructure and texture after processing. A significantly reduced texture formation was observed with the novel alloy. The hardness of the consolidated material shows superior properties for ODS-containing TiAl compared to ODS-free material. This work provides a first step towards tailored alloys for AM and the production of ODS TiAl alloys

    Chlorine-induced stress corrosion cracking of single crystal superalloys at 550 °C

    Get PDF
    This study has investigated the effect of NaCl and different gaseous environments on the stress corrosion cracking susceptibility of CMSX-4 at 550 °C. The presence of SOx leads to the rapid dissociation of NaCl into Na2SO4 and the release Cl2 and HCl, which then trigger an active oxidation mechanism and stress corrosion cracking. The incubation time for crack initiation at 690 MPa and in the presence of a sulphur containing environment is 10 min. A working hypothesis is that stress corrosion cracking occurs due to the hydrogen released at the oxide/alloy interface when metal chlorides are formed; however, this hypothesis needs to be further explored.Rolls RoyceHigh Temperature Corrosion of Material

    Efficacy and safety of alirocumab in insulin-treated patients with type 1 or type 2 diabetes and high cardiovascular risk:Rationale and design of the ODYSSEY DM-INSULIN trial

    Get PDF
    Aims: The coadministration of alirocumab, a PCSK9 inhibitor for treatment of hypercholesterolaemia, and insulin in diabetes mellitus (DM) requires further study. Described here is the rationale behind a phase-IIIb study designed to characterize the efficacy and safety of alirocumab in insulin-treated patients with type 1 (T1) or type 2 (T2) DM with hypercholesterolaemia and high cardiovascular (CV) risk. Methods: ODYSSEY DM-INSULIN (NCT02585778) is a randomized, double-blind, placebo-controlled, multicentre study that planned to enrol around 400 T2 and up to 100 T1 insulin-treated DM patients. Participants had low-density lipoprotein cholesterol (LDL-C) levels at screening. ≥. 70. mg/dL (1.81. mmol/L) with stable maximum tolerated statin therapy or were statin-intolerant, and taking (or not) other lipid-lowering therapy; they also had established CV disease or at least one additional CV risk factor. Eligible patients were randomized 2:1 to 24. weeks of alirocumab 75. mg every 2. weeks (Q2W) or a placebo. Alirocumab-treated patients with LDL-C. ≥. 70. mg/dL at week 8 underwent a blinded dose increase to 150. mg Q2W at week 12. Primary endpoints were the difference between treatment arms in percentage change of calculated LDL-C from baseline to week 24, and alirocumab safety. Results: This is an ongoing clinical trial, with 76 T1 and 441 T2 DM patients enrolled; results are expected in mid-2017. Conclusion: The ODYSSEY DM-INSULIN study will provide information on the efficacy and safety of alirocumab in insulin-treated individuals with T1 or T2 DM who are at high CV risk and have hypercholesterolaemia not adequately controlled by the maximum tolerated statin therapy

    Novel inhibitors of the calcineurin/NFATc hub - alternatives to CsA and FK506?

    Get PDF
    The drugs cyclosporine A (CsA) and tacrolimus (FK506) revolutionized organ transplantation. Both compounds are still widely used in the clinic as well as for basic research, even though they have dramatic side effects and modulate other pathways than calcineurin-NFATc, too. To answer the major open question - whether the adverse side effects are secondary to the actions of the drugs on the calcineurin-NFATc pathway - alternative inhibitors were developed. Ideal inhibitors should discriminate between the inhibition of (i) calcineurin and peptidyl-prolyl cis-trans isomerases (PPIases; the matchmaker proteins of CsA and FK506), (ii) calcineurin and the other Ser/Thr protein phosphatases, and (iii) NFATc and other transcription factors. In this review we summarize the current knowledge about novel inhibitors, synthesized or identified in the last decades, and focus on their mode of action, specificity, and biological effects
    • …
    corecore